Next Article in Journal
The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease
Next Article in Special Issue
Common Structural Pattern for Flecainide Binding in Atrial-Selective Kv1.5 and Nav1.5 Channels: A Computational Approach
Previous Article in Journal
Genetic Factors of Renin–Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants
Previous Article in Special Issue
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 232; https://doi.org/10.3390/pharmaceutics14020232
Action Date Notes Link
article xml file uploaded 19 January 2022 17:03 CET Original file -
article xml uploaded. 19 January 2022 17:03 CET Update https://www.mdpi.com/1999-4923/14/2/232/xml
article pdf uploaded. 19 January 2022 17:03 CET Version of Record https://www.mdpi.com/1999-4923/14/2/232/pdf
article supplementary file uploaded. 19 January 2022 17:03 CET - https://www.mdpi.com/1999-4923/14/2/232#supplementary
article html file updated 19 January 2022 17:04 CET Original file -
article html file updated 31 July 2022 04:48 CEST Update https://www.mdpi.com/1999-4923/14/2/232/html
Back to TopTop